Publications

Ma J, Lai CQ, Li XS, Wang M, Wang Z, Yao J, Guo X, Taylor KD, Lee S, Tracy RP, Peter D, Liu Y, Rotter[...]

By afschroeder • February 9, 2026

Funnell AJ, Petousis P, Harel-Canada F, Romero R, Bui AAT, Koncsol A, Chaturvedi H, Shover C, Goodman-Meza D. Improving drug identification in overdose death surveillance[...]

By afschroeder • February 9, 2026

Prabaker K, Zhuo R, Malhotra S, Yang S, Match C, Turay S, Bluntson E, Walton S, Dogan T, Uslan D. Clinical and operational impact of[...]

By afschroeder • February 9, 2026

Torres AJ, Dimas VV, Shahanavaz S, Balzer D, Morgan G, Lim DS, Armstrong AK, Berman D, Babaliaros V, Kim D, Gillespie MJ, Sommer R, Aboulhosn[...]

By afschroeder • February 9, 2026

Brooks MJ, MacLean SA, Eschliman EL, Poku OB, Molebatsi K, Ahmed C, Morakanyane P, Entaile P, Monyane-Pheko M, Morapedi K, Phoi O, Tshume O, Benton[...]

By afschroeder • February 8, 2026

Perez JS, Hudson H, Araneta J, Bedell B, Aikins AD, Dugas LR, Eid M, Eshac Y, Fariduddin M, Fariduddin M, Jong K, Kapwata T, Luke[...]

By afschroeder • February 7, 2026

Jajoo A, Margolin K, Limketkai BN, Parian A. Evolution of Advanced Combination Treatment in Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y). 2025 Dec;21(12):745-756. PMID: 41647471;[...]

By afschroeder • February 7, 2026

Nafissi N, Mahadevan A, Chiao E, Rijal N, Parajuli R. Triple Negative Breast Cancer With Choroidal Metastasis Responsive to Sacituzumab Govitecan and Radiation Therapy. Cancer[...]

By afschroeder • February 7, 2026

Katz A, Nong Y, Ma EJ, Roberts AM, Chou PP, Jeong CY, Yan MJ, Johnsen N, Armstrong AW. Effects of GLP-1 Receptor Agonists on Major[...]

By afschroeder • February 7, 2026

Karunanandaa K, Knoche EM, Montgomery RB, Pickett C, Doherty J, Gruber J, Raychaudhuri R, Eaton D, Garraway IP, Rettig M, Maxwell KN, Schoen MW. Tumor[...]

By afschroeder • February 7, 2026